Download - M. Tuberculosis and immune responses
![Page 1: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/1.jpg)
In the Name of God
![Page 2: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/2.jpg)
M. Tuberculosis and
immune responses
Presented By : M. Barabadi , S. Keshavarz Shahbaz
Supervised by : Dr. Noorbakhsh
Tehran university of medical science
![Page 3: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/3.jpg)
Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB
• Experimental models• Immune response against TB
- Innate immune defense- Adaptive immune defense
• HIV and TB• Difficulties and advantages in TB research• Risk factors
![Page 4: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/4.jpg)
![Page 5: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/5.jpg)
![Page 6: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/6.jpg)
![Page 7: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/7.jpg)
![Page 8: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/8.jpg)
![Page 9: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/9.jpg)
![Page 10: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/10.jpg)
![Page 11: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/11.jpg)
![Page 12: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/12.jpg)
![Page 13: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/13.jpg)
![Page 14: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/14.jpg)
Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB
• Experimental models• Immune response against TB
- Innate immune defense- Adaptive immune defense
• HIV and TB• Difficulties and advantages in TB reaserch• Risk factors
![Page 15: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/15.jpg)
![Page 16: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/16.jpg)
![Page 17: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/17.jpg)
The pathogen structure:
![Page 18: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/18.jpg)
![Page 19: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/19.jpg)
![Page 20: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/20.jpg)
Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB
• Experimental models• Immune response against TB
- Innate immune defense- Adaptive immune defense
• HIV and TB• Difficulties and advantages in TB reaserch• Risk factors
![Page 21: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/21.jpg)
M. Tuberculosis Characteristics
• Slow-growing• Facultative Intracellular• Gram-positive• Non Spore Forming• Aerobic• Acid-fast bacilli
![Page 22: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/22.jpg)
![Page 23: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/23.jpg)
Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB
• Experimental models• Immune response against TB
- Innate immune defense- Adaptive immune defense
• HIV and TB• Difficulties and advantages in TB reaserch• Risk factors
![Page 24: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/24.jpg)
![Page 25: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/25.jpg)
Spine TB :
Nemhotep,Priest of Amun died about 1000 BCE
![Page 26: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/26.jpg)
Brain TB :
![Page 28: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/28.jpg)
![Page 29: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/29.jpg)
Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB
• Experimental models• Immune response against TB
- Innate immune defense- Adaptive immune defense
• HIV and TB• Difficulties and advantages in TB reaserch• Risk factors
![Page 30: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/30.jpg)
The TB Song.flv
![Page 31: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/31.jpg)
![Page 32: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/32.jpg)
Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB
• Experimental models• Immune response against TB
- Innate immune defense- Adaptive immune defense
• HIV and TB• Difficulties and advantages in TB reaserch• Risk factors
![Page 33: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/33.jpg)
![Page 34: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/34.jpg)
![Page 35: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/35.jpg)
![Page 36: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/36.jpg)
![Page 37: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/37.jpg)
![Page 38: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/38.jpg)
Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB
• Experimental models• Immune response against TB
- Innate immune defense- Adaptive immune defense
• HIV and TB• Difficulties and advantages in TB research• Risk factors
![Page 39: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/39.jpg)
Active vs. latent TB :
Tuberculosis.flv
![Page 40: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/40.jpg)
Active TB :
![Page 41: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/41.jpg)
Active TB:
• Two Forms :1. Primary-progressive TB (more common in
children) :Progress rapidly to active disease
2. Post-primary TB: present after an interval of many years following exposure
![Page 42: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/42.jpg)
Differences :
I. Clinical presentations II. Different temporal pathogenesisIII. Host genetic susceptibilities
![Page 43: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/43.jpg)
Diagnosis :
![Page 44: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/44.jpg)
![Page 45: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/45.jpg)
![Page 46: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/46.jpg)
M.TB visualization using the Ziehl–Neelsen stain :
![Page 47: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/47.jpg)
M. TB bacterial colonies
Isolation and confirmation of TB by culture take up to 6 weeks .
![Page 48: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/48.jpg)
• 2 months after treatment ,the culture from sputum becomes negative. It is the only accepted biomarker but with low sensitivity and modest specificity .
![Page 49: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/49.jpg)
• Confirmation of Diagnosis is necessary Because clinical presentation of TB is nonspecific and overlaps with:
- pneumonia- lung cancer- sarcoidosis
![Page 50: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/50.jpg)
Xpert MTB/RIF automated molecular PCR
• A cartridge-based, automated diagnostic test that can identify MTB and resistance to rifampicin.
• WHO recently endorsed this method.
• It answers in just 2 hour.
![Page 51: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/51.jpg)
Treatment • The treatment is lengthy (a minimum of 6
months)• It requires the use of multiple drugs to prevent
the selection of drug-resistant mutants.
• It is divided into :A. initial intensive phase : to kill actively
replicating bacilliB. continuation phase : to target persisting bacilli
![Page 52: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/52.jpg)
Blood Transcriptional profiling in Active TB:
• In This method we gain an understanding of immune response and potential factor that lead to the pathogenesis of TB
![Page 53: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/53.jpg)
• 393-transcript signature, present in the blood of patients with active TB ,that was absent in most latent individuals and healthy controls.
• transcriptional signature of active TB is dominated by IFN-inducible signature
![Page 54: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/54.jpg)
![Page 55: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/55.jpg)
Detrimental role of Type1 IFN :
• patients with active TB have a prominent type I IFN–inducible gene signature in their blood that correlated with the extent of radiographic disease and diminished upon successful treatment
![Page 56: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/56.jpg)
Active TB heatmap :
![Page 57: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/57.jpg)
Advantage :
• Early change in the blood transcriptional signature --->2 weeks after treatment
• sputum smear ---> atfer2 months of treatment
![Page 58: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/58.jpg)
• sarcoidosis patients have a similarity to M.TB patients :
They have significant overlap in the IFN-inducible genes that leads to similar immune mechanisms of granulomatous.
![Page 59: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/59.jpg)
![Page 60: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/60.jpg)
Latent TB :
![Page 61: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/61.jpg)
Latent TB :
• Most infected individuals are asymptomatic• 5–10% of latent individuals will develop active
TB during their lifetime• individuals who are immunosuppressed,
particularly those with HIV coinfection are in Higher risk
![Page 62: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/62.jpg)
Diagnosis :
![Page 63: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/63.jpg)
![Page 64: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/64.jpg)
• Tuberculin skin test (TST) is common
• TST is more frequently negative in those individuals most at risk of progression to active disease:
a) the young b) the elderlyc) immunosuppressed
![Page 65: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/65.jpg)
False positive TST
• PPD is prepared from culture filtrate of TB• It contains over 200 antigens also found in the
attenuated BCG vaccine and in many environmental non-TB mycobacteria
Therefore TST has limited specificity
![Page 66: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/66.jpg)
IGRAs :• More specific TB antigens :1. early secretory antigen target-6 (ESAT-6)2. culture filtrate protein- 10 (CFP-10) are absent from BCG and most non-TB is used
• Reactivity to these TB antigens is assessed in terms of production of IFN-γ by blood cells using IFN-γ release assays (IGRAs).
• IGRAs is measured by :1. ELISA 2. ELI-SPOT
![Page 67: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/67.jpg)
Heterogeneity of latent TB :
![Page 68: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/68.jpg)
Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB
• Experimental models• Immune response against TB
- Innate immune defense- Adaptive immune defense
• HIV and TB• Difficulties and advantages in TB research• Risk factors
![Page 69: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/69.jpg)
Human TB and experimental animal models :
• The mouse model offers the best tools for the study of the immune response to TB
• Commonly used mouse strains, such as C57BL/6 or BALB/c mice
• Highly susceptible strain : CBA/J, DBA/2, and C3H
• Advantage:• Infected with low dose virulent TB• Disadvantage:• The granulomas are poorly organized and exclusively cellular• They lack fibrosis or hypoxia • The mice ultimately die • lacks the range of latency to active disease
![Page 70: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/70.jpg)
cynomolgus macaque model It is the most commonly used model for studying latent TB The heterogeneous TB experimental model
![Page 71: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/71.jpg)
Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB
• Experimental models• Immune response against TB
- Innate immune defense- Adaptive immune defense
• HIV and TB• Difficulties and advantages in TB research• Risk factors
![Page 72: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/72.jpg)
Immune response in TB :
1. Formation of Granulomas2. Initials events3. MQ apoptosis4. Role of PMN(Neu)
![Page 73: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/73.jpg)
Formation of Granulomas
Tuberculosis Invasion.mp4
![Page 74: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/74.jpg)
![Page 75: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/75.jpg)
![Page 76: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/76.jpg)
• The classical feature of human TB granulomas:
The presence of a necrotic caseous core that is thought to be secondary to cell lysis that results in a central hypoxic environment .
![Page 77: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/77.jpg)
Caseation necrosis :
![Page 78: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/78.jpg)
Granuloma in active & latent TB :
• In latent TB the bacilli reside in the central hypoxic zone in a metabolically altered state
• In active TB they can replicate in peripheral oxygenated areas.
• Are they purely protective for the host or do they promote infection?
• The pathogen may be able to engineer a supportive environment in the granuloma
![Page 79: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/79.jpg)
Granuloma classification in active TB:
1. The classical caseous granuloma :central eosinophilic debris surrounded by macrophages and a layer of lymphocytes
2. The non-necrotizing granuloma: internal core of macrophages and some neutrophils surrounded by a lymphocyte layer
3. The suppurative granuloma: central core of degenerative neutrophils surrounded by macrophages and multinucleated giant cells and an outer envelope of lymphocytes
![Page 80: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/80.jpg)
![Page 81: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/81.jpg)
First line of defence• Influx of phagocytic cells including :1. primarily resident alveolar MQ2. recruited neutrophils and DCs• Escape : TB prevents phagolysosomal fusion
and persist in the phagosome• Immune defense: Opsonization of the bacilli
prior to infection inhibits this blockade of phagolysosomal fusion
![Page 82: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/82.jpg)
Role of MQ :
• Infection of MQ with M.TB can induce:1. necrotic death: allows exit from MQ and
therefore cell-to-cell spread of the bacilli
2. Apoptotic death : is associated with diminished pathogen viability and enhanced immunity
![Page 83: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/83.jpg)
Efferocytosis
• TB –infected MQ are themselves rapidly engulfed by uninfected MQ through a process called efferocytosis , generally regarded as a constitutive housekeeping function of macrophages.
![Page 84: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/84.jpg)
![Page 85: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/85.jpg)
• The type of cell death is regulated by : The lipid mediators include :1. (proapoptotics): eicosanoids , prostaglandin E2
(PGE2) 2. (pronecrotic): lipoxin A4 (LXA4)
• Virulent strains of TB evade innate defense mechanisms of the host by inducing LXA4 and inhibiting PGE2 production
• They lead to MQ necrosis and inhibition of MQ apoptosis, ultimately resulting in mycobacterial spread.
![Page 86: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/86.jpg)
Role of Neutrophils • Lung Neu facilitate activation of naive antigen-specificCD4+
Tcells during M .TB infection.• IT promote an anti–M.TB adaptive immune response by
delivering the bacilli to DCs in a form that makes DCs more effective initiators of CD4+ T cell activation.
• Neu have a protective or detrimental effect during an immune response to TB infection may be determined by:
1. The genetics of the pathogen as well as by the genetics of the host
2. The stage of TB disease3. Tissue environment4. Network of cytokines
![Page 87: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/87.jpg)
Detrimental role of Neu : • Neutrophils are dominant producers of IL-10
in the lung .
• Depletion of neutrophils reduces the lung bacterial load while enhancing IL-6 and IL-17, but not IFN-γ, responses
![Page 88: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/88.jpg)
![Page 89: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/89.jpg)
Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB
• Experimental models• Immune response against TB
- Innate immune defense- Adaptive immune defense
• HIV and TB• Difficulties and advantages in TB research• Risk factors
![Page 90: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/90.jpg)
Innate immune factors :
1. TNF2. Inflammation3. Pattern recognition receptors ,Adaptor
proteins
![Page 91: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/91.jpg)
TNF• Role :1. Formation and maintenance of the integrity of the
granuloma 2. Boosting the intracellular killing of bacilli
• Granuloma formation could occur even in the absence of TNF signaling, but these granulomas were :
• Delayed• More necrotic • With higher bacillary numbers.
![Page 92: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/92.jpg)
Inflammation :
1. Eicosanoids2. Matrix metalloproteinases : MMP-1 and MMP-9 : key collagenase upregulated in patients with TB and associated with increased lung pathology in transgenic mice 3. Vitamin Da pro-hormone that in kidney converts to its active form .Conversion can also occur in granulomatous tissue.
![Page 93: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/93.jpg)
• Vit D3 has regulatory and anti-inflammatory immune effects ,therefore continues to be of potential therapeutic interest.
• Historically ,sunlight exposure and vitamin D were used as treatments for TB.
![Page 94: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/94.jpg)
Pattern recognition receptors and Adaptor proteins :
• Pattern-recognition receptors (PRRs): 1. Toll-like receptors (TLRs)2. C-type lectin receptors (CLRs)including
dectin-1, mannose receptor, and DC-SIGN3. Nod-like receptors (NLRs)
![Page 95: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/95.jpg)
• MyD88 and CARD9 :- master adaptors of TLR - critical for protective immunity to M.TB in mouse models
• TLR2, TLR4, and TLR9 play a role in host recognition of M.TB
![Page 96: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/96.jpg)
Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB
• Experimental models• Immune response against TB
- Innate immune defense- Adaptive immune defense
• HIV and TB• Difficulties and advantages in TB research• Risk factors
![Page 97: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/97.jpg)
Adaptive immune response :
1. T cells2. DC cells3. CD-1 restricted response4. B cell5. Cytokines
![Page 98: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/98.jpg)
DC cell• DCs in lymph nodes from patients with M.TB may themselves
contain M.TB
• Depletion of CD11c+ cells in mice before intravenous infection with M.TB delays the development of CD4+ T cell responses
![Page 99: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/99.jpg)
T cells
• The most important T cells is CD4+ T cells
• CD8+ T cells also contribute to anti-TB immunity by:1. Secreting IFNγ To Activate MQ to Control Infection 2. Secreting products that can directly kill The TB
bacilli.
• However, CD8+ T cells clearly can not compensate for a lack of CD4+ T cells.
![Page 100: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/100.jpg)
![Page 101: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/101.jpg)
CD1-Restricted Responses
• TB contains glycolipid Ag that are presented by The CD1 family molecules
• Glycolipid-reactive T cells play a role in an effective response to TB
• They proliferate and produce IFN-γ in response to TB glycolipids
![Page 102: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/102.jpg)
B cells
• Follicle-like B cell have been observed in the lungs of M.TB patients and in the granulomas of infected mice
• Role :1. moderate inflammatory progression 2. modulating immune activation and
susceptibility to infection by induction of IL-10
![Page 103: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/103.jpg)
IFNγ
• The most invariably detected cytokine at the sites of human TB infection in :
- Lung (most )- bronchoalveolar lavage (BAL) fluid- pleuritis fluid- lymph nodes
![Page 104: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/104.jpg)
IFN-γ-Mediated Killingin MQ :
IFN-γ-inducible molecules include: • iNOS , LRG-47, an IFN inducible GTP-binding
protein
• IFN-γ is also important for endosome maturation and the induction of antimicrobial peptide
![Page 105: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/105.jpg)
![Page 106: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/106.jpg)
Control of Inflammation and CD4+T Cells
• various mechanisms are in place to prevent immunopathology, including:
1. Foxp3+ regulatory T cells2. IL-10 3. PD1 ( expressed by T cells from TB patients)
![Page 107: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/107.jpg)
• PD-L1 is overly abundant in the whole blood of active TB patients
PD1 binded to PDl1---> negative signal chronic infection
PD1 deletion ---- > increase of M.TB-specific CD4+ T cell --- > active TB
• This finding demonstrated the importance of a finely regulated immune response to control disease.
![Page 108: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/108.jpg)
IL-17 :
• Both IFN-γ and IL-17-producing T cells are induced during mycobacterial infection
• IFN-γ serves to limit the IL-17-producing T cell population
• IL-17 can also be produced by γδ T cells and a non-CD4+ CD8+ population .
• Role :- Granuloma formation- Th1 enhancement
![Page 109: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/109.jpg)
Following BCG vaccination with a mycobacterial peptide:
IL-17 is required for the accelerated recruitment of IFN-γ-producing cells to the lung as a result of increased concentrations of the chemokines CXCL9, 10, and 11, which recruit cells to sites of inflammation
![Page 110: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/110.jpg)
IL 23
• Essential for the IL-17 response during TB• Dispensable for protection and antigen-
specific IFN-γ responses if IL-12p70 is available
![Page 111: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/111.jpg)
The double-edged sword of suppressivecytokines in tuberculosis
• IL10
• TH2 cytokine
• Type1 IFN
![Page 112: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/112.jpg)
IL10• An immunosuppressive cytokine induced by TB
for immune evasion • If overproduced, IL-10 can contribute to
chronic infection
• IL-10 was elevated in the lungs , BAL fluid , sputum and serum of active TB patients
![Page 113: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/113.jpg)
• Activation of TLR4 (but not of TLR2) will induce higher levels of IL-10 production by MQ
• Bone marrow–derived Neu infected in vitro or Neu isolated from the lungs of mice challenged with TB produce significant levels of IL-10
![Page 114: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/114.jpg)
Th2 Cytokines
• Chronic worm infection of mice reduces immunogenicity to M.TB and reduce Th1 responses.
• Generally ,Helminthes reduce protective immune responses to M.TB infection.
![Page 115: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/115.jpg)
Type I IFNs
• The type I IFN family of cytokines have pleiotropic effects on the broader immune response
• Role :1. Increases susceptibility to M.TB 2. Suppresses production of host-protective
cytokines including IL-1 and IL-12 following M.TB infection in MQ
3. Induction of the immunosuppressive cytokine IL-10
![Page 116: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/116.jpg)
Outline :• TB history• TB epidemiology• M TB bacteriology• TB clinical features - symptoms and signs - transmission - active vs. latent TB
• Experimental models• Immune response against TB
- Innate immune defense- Adaptive immune defense
• HIV and TB• Difficulties and advantages in TB research• Risk factors
![Page 117: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/117.jpg)
HIV and TB :
• TB is the most common opportunistic infection worldwide in HIV-1-infected persons
• Antiretroviral therapy (ART) for HIV-1 infection improves immune resistance to TB
• Vitamin D reportedly inhibits HIV-1 and TB infection in MQ through the induction of autophagy.
![Page 118: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/118.jpg)
![Page 119: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/119.jpg)
TB-IRIS
• HIV+ patient ---> immunosuppressed--->ART----> decreased viral load and increased CD4+ T cells ---> sudden over activation of immune system ----> rapid recognition of pathogens in body (like TB ) ----> causes severe systemic inflammatory disease
![Page 120: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/120.jpg)
Outline :• M TB history• M TB epidemiology• M TB bacteriology• TB clinical feature - symptoms - transmission - active vs. latent TB
• Experimental models• Immune response against TB
- Innate immune defense- Adaptive immune defense
• HIV and TB• Difficulties and advantages in TB research• Risk factors
![Page 121: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/121.jpg)
![Page 122: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/122.jpg)
Outline :• M TB history• M TB epidemiology• M TB bacteriology• TB clinical feature - symptoms - transmission - active vs. latent TB
• Experimental models• Immune response against TB
- Innate immune defense- Adaptive immune defense
• HIV and TB• Difficulties and advantages in studying• Risk factors
![Page 123: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/123.jpg)
![Page 124: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/124.jpg)
![Page 125: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/125.jpg)
![Page 126: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/126.jpg)
![Page 127: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/127.jpg)
![Page 128: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/128.jpg)
![Page 129: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/129.jpg)
![Page 130: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/130.jpg)
![Page 131: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/131.jpg)
![Page 132: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/132.jpg)
![Page 133: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/133.jpg)
![Page 134: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/134.jpg)
![Page 135: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/135.jpg)
![Page 136: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/136.jpg)
Reference :
![Page 137: M. Tuberculosis and immune responses](https://reader038.vdocument.in/reader038/viewer/2022110118/554b3c6bb4c905ff268b48ba/html5/thumbnails/137.jpg)
Thanks for your
attention